Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Six Month, Double Blind, Placebo-controlled Trial of the Efficacy of Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

NCT01573637 is registered in ClinicalTrials.gov with Fundació Sant Joan de Déu as lead sponsor.

NCT NCT01573637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01573637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Six Month, Double Blind, Placebo-controlled Trial of the Efficacy of Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Lead sponsor
Fundació Sant Joan de Déu
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2014
Enrollment
78 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia in post menopausal women